We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nalge Nunc to Market BioCrystal's OptiCell

By HospiMedica staff writers
Posted on 21 Aug 2006
Nalge Nunc International Corporation (Rochester, NY, USA) has entered into a partnership with BioCrystal, Ltd. More...
(Westerville, OH, USA) and acquired global distribution rights of OptiCell and related new products. OptiCell was developed by BioCrystal for cell cultures. The product will be sold and supported globally through the Nalge Nunc international distribution network under the brand name Nunc OptiCell.

The OptiCell device consists of gas-permeable polymer membranes that provide a cell culture growth surface area enclosed within a sealed environment. It accommodates adherent or non-adherent cells and enables visual access to living cells using standard imaging equipment. OptiCell's culture chamber enables cell growth on two parallel, gas-permeable membranes with only 10 ml of cell culture media or reagents.

A rack of 20 OptiCells provides growth surface equivalent to 27 T-75 (75 cm2) culture flasks, in one-fifth the incubation space. Self-sealing access ports greatly reduce risk of contamination, and the clear crystal polystyrene membrane allows high quality imaging of cells. Membranes can be sectioned, making OptiCell useful for cytostaining, transfection, and single cell cloning. The device is ideal for continuous monoclonal antibody production.

Nalge Nunc International is engaged in the design, development, and manufacture of plastic products for use in labware, packaging, biotechnology, and life science applications. "We are pleased to have joined with BioCrystal in bringing this exciting technology to the biomedical research community,” said Steve Silverman, vice president, marketing and product development, Nalge Nunc. "OptiCell further expands the available technologies we provide for in vitro cell culture,” he added.



Related Links:
Nalge Nunc
BioCrystal

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.